Chinese company to buy Complete Genomics, keep HQ in Mountain View

Complete Genomics' Cliff Reid.

A Chinese company will buy human genome sequencing company Complete Genomics Inc. for $113 million, the companies said Monday, and provide $30 million in bridge financing for operations after signing a merger agreement. A U.S. subsidiary of BGI-Shenzhen, which includes nonprofit genomic research institutes and sequencing application commercial units, will launch a tender offer to buy all the outstanding shares of common stock in Mountain View-based Complete Genomics (NASDAQ: GNOM) for $3.15 per share cash. The price represents an 18 percent premium over Complete Genomics' $2.67 closing price on Friday.